Brief: Predictive Oncology Validates Discovery 21 Proof-Of-Concept Campaign
24/03/2022 13:08
March 24 (Reuters) - Predictive Oncology Inc POAI.O :
* PREDICTIVE ONCOLOGY VALIDATES DISCOVERY 21
PROOF-OF-CONCEPT
CAMPAIGN
Source text for Eikon: ID:nGNX1LLcm3
Further company coverage: POAI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Axe Compute
See all newsBrief: Axe Compute Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Axe Compute Receives $317 Million In Customer Prepayments Under Global Ai Infrastructure Contracts
Brief: Duos Technologies Signs Five-Year, 55 MW Hosting Agreements With Axe Compute Valued At Over $500 Million
Brief: Axe Compute And Duos Technologies Enter Into Agreements For 55 MW Of New Ai Data Center Capacity Across Multiple U.S. Locations
GPU capacity provider Axe Compute's Q2 revenue surges